Eric Yvon

Medicine · Health Sciences

31h-index5.2kcitations110works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(51), Immune Cell Function and Interaction(46), Immunotherapy and Immune Responses(22), Hematopoietic Stem Cell Transplantation(20), T-cell and B-cell Immunology(17)

Publications108 total

Co-transducing B7H3 CAR-NK cells with the DNR preserves their cytolytic function against GBM in the presence of exogenous TGF-β
UNC Libraries·2024Open Access
Supplementary Data from Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T cells
2023Open Access
Data from Engineering the TGFβ Receptor to Enhance the Therapeutic Potential of Natural Killer Cells as an Immunotherapy for Neuroblastoma
2023Open Access
Supplementary Figure 6 from T Lymphocytes Redirected against the Chondroitin Sulfate Proteoglycan-4 Control the Growth of Multiple Solid Tumors both <i>In Vitro</i> and <i>In Vivo</i>
2023Open Access
Data from Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T cells
2023Open Access
Supplementary Figure 3 from T Lymphocytes Redirected against the Chondroitin Sulfate Proteoglycan-4 Control the Growth of Multiple Solid Tumors both <i>In Vitro</i> and <i>In Vivo</i>
2023Open Access
Data from T Lymphocytes Redirected against the Chondroitin Sulfate Proteoglycan-4 Control the Growth of Multiple Solid Tumors both <i>In Vitro</i> and <i>In Vivo</i>
2023Open Access
Supplementary Figure 6 from T Lymphocytes Redirected against the Chondroitin Sulfate Proteoglycan-4 Control the Growth of Multiple Solid Tumors both <i>In Vitro</i> and <i>In Vivo</i>
2023Open Access
Supplementary Data from Engineering the TGFβ Receptor to Enhance the Therapeutic Potential of Natural Killer Cells as an Immunotherapy for Neuroblastoma
2023Open Access
Supplementary Figure 5 from T Lymphocytes Redirected against the Chondroitin Sulfate Proteoglycan-4 Control the Growth of Multiple Solid Tumors both <i>In Vitro</i> and <i>In Vivo</i>
2023Open Access
Supplementary Figure Legend from T Lymphocytes Redirected against the Chondroitin Sulfate Proteoglycan-4 Control the Growth of Multiple Solid Tumors both <i>In Vitro</i> and <i>In Vivo</i>
2023Open Access
Supplementary Figure 1 from Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity
2023Open Access
Supplementary Figure 5 from T Lymphocytes Redirected against the Chondroitin Sulfate Proteoglycan-4 Control the Growth of Multiple Solid Tumors both <i>In Vitro</i> and <i>In Vivo</i>
2023Open Access
Supplementary Figure 4 from T Lymphocytes Redirected against the Chondroitin Sulfate Proteoglycan-4 Control the Growth of Multiple Solid Tumors both <i>In Vitro</i> and <i>In Vivo</i>
2023Open Access
Data from Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T cells
2023Open Access
Supplementary Data from Engineering the TGFβ Receptor to Enhance the Therapeutic Potential of Natural Killer Cells as an Immunotherapy for Neuroblastoma
2023Open Access
Supplementary Tables 1 - 2 from Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity
2023Open Access
Supplementary Figure 2 from T Lymphocytes Redirected against the Chondroitin Sulfate Proteoglycan-4 Control the Growth of Multiple Solid Tumors both <i>In Vitro</i> and <i>In Vivo</i>
2023Open Access
Supplementary Figure 2 from T Lymphocytes Redirected against the Chondroitin Sulfate Proteoglycan-4 Control the Growth of Multiple Solid Tumors both <i>In Vitro</i> and <i>In Vivo</i>
2023Open Access
Supplementary Figure 3 from T Lymphocytes Redirected against the Chondroitin Sulfate Proteoglycan-4 Control the Growth of Multiple Solid Tumors both <i>In Vitro</i> and <i>In Vivo</i>
2023Open Access
page 1 of 6Next →

Frequent Co-authors

Malcolm K. Brenner(18), Gianpietro Dotti(16), Elizabeth J. Shpall(13), Helen E. Heslop(12), Catherine M. Bollard(12), Cliona M. Rooney(10), Simrit Parmar(10), Barbara Savoldo(9), Nina Shah(8), Richard E. Champlin(8), Ettore Biagi(8), Sairah Ahmed(7), Ian McNiece(7), Enli Liu(6), Dean A. Lee(6), Katy Rezvani(6), Katayoun Rezvani(6), Indreshpal Kaur(5), Hila Shaim(5), Muharrem Müftüoğlu(5)